Healthcare Jul 28, 2021 03:47 PM (GMT+8) · EqualOcean
Enhua pharmaceutical announced that it had signed the drug development and licensing agreement with Belgium COMPLIX + NV company to cooperate in the research and development of innovative biological drugs for drug targets in the central nervous system by using COMPLIX's proprietary cell transmembrane antibody "cpabs" technology platform.